Health
Novavax coronavirus vaccine shown to be 89 per cent effective in UK trial – SBS News
A mid-stage trial of the vaccine in South Africa, where a new variant of the virus is common, showed 60 per cent effectiveness among people who did not have HIV….
Novavax Inc said on Thursday its vaccine was 89.3 per cent effective in preventing COVID-19 in a trial conducted in the United Kingdom, and was nearly as effective in protecting against the more highly contagious variant first discovered there, according to a preliminary analysis.
A mid-stage trial of the vaccine in South Africa, where a troubling new variant of the virus is common, showed 60 per cent effectiveness among people who did not have HIV.
Novavax shares surged 34 per cent in after hours…
-
Business22 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News22 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Business18 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News21 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses